Doctor profile · Federal record
Dr. Richard Burroughs, M.D.
Dermatology Physician (CMS: Dermatology) · Washington, DC
- NPI 1649250101
- 24 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
6900 Georgia Ave Nw
Washington, DC 203070003
(202) 782-6173 - Mailing address
-
463 Wyndgate RD
Sacramento, CA 958645937
Credentials & registration
- NPI registered
- January 2006 — 20 yrs on file
- Profile last updated
- January 27, 2011
- Year of graduation
- 2002 — 24 yrs since
- Specialty taxonomy
- 207N00000X — NUCC code
- State license (1)
- California #A85841
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1649250101. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
723
Distinct HCPCS
9
Medicare allowed
$80,797
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 384 | 196 | $104 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 66 | 66 | $131 | |
17110 |
Destruction of skin growth, 1-14 growths | 58 | 42 | $140 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 55 | 46 | $146 | |
11102 |
Biopsy of related skin growth, first growth | 49 | 46 | $118 | |
99202 |
New patient office or other outpatient visit, 15-29 minutes | 43 | 43 | $83 | |
99212 |
Established patient office or other outpatient visit, 10-19 minutes | 31 | 27 | $67 | |
11104 |
Punch biopsy, first skin growth | 23 | 21 | $154 | |
17000 |
Destruction of precancer skin growth, 1 growth | 14 | 12 | $70 |
In context: peer comparison
Among 24 peers in this city , average services per provider: 200. This provider delivers 3.6× the peer median.Open Payments
Industry payments received
All-time total
$3,734
Transactions
184
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| ABBVIE INC. | 71 | $1,271.90 | |
| GENZYME CORPORATION | 16 | $331.56 | |
| Lilly USA, LLC | 14 | $312.48 | |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 10 | $281.14 | |
| PFIZER INC. | 11 | $193.86 | |
| Regeneron Healthcare Solutions, Inc. | 4 | $166.60 | |
| Janssen Biotech, Inc. | 6 | $157.41 | |
| Amgen Inc. | 8 | $150.18 | |
| E.R. Squibb & Sons, L.L.C. | 7 | $148.11 | |
| Incyte Corporation | 14 | $144.54 | |
| Arcutis Biotherapeutics, Inc. | 9 | $137.65 | |
| Dermavant Sciences, Inc. | 5 | $105.15 | |
| Galderma Laboratories, L.P. | 3 | $79.87 | |
| LEO Pharma Inc. | 4 | $64.75 | |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $52.86 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
891
Patients
488
Total drug cost
$99,276
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Triamcinolone Acetonide | Generic | 204 | 125 | $1,357 |
| Fluocinonide | Generic | 133 | 78 | $7,548 |
| Ketoconazole | Generic | 111 | 56 | $2,212 |
| Betamethasone Diprop Augmented (Betamethasone/Propylene Glyc) | Brand | 94 | 46 | $6,305 |
| Doxycycline Hyclate | Generic | 50 | 21 | $2,264 |
| Nystatin-Triamcinolone (Nystatin/Triamcinolone Acet) | Brand | 44 | 27 | $1,601 |
| Nystatin | Generic | 41 | 28 | $622 |
| Fluorouracil | Generic | 37 | 32 | $4,133 |
| Doxycycline Monohydrate | Generic | 35 | 12 | $1,955 |
| Clindamycin Phosphate | Generic | 34 | 12 | $2,449 |
Frequently asked questions
What is Dr. Richard Burroughs's medical specialty?
Dr. Richard Burroughs practices Dermatology Physician in Washington, DC.
Where does Dr. Richard Burroughs practice?
Dr. Richard Burroughs practices at 6900 Georgia Ave Nw, Washington, DC 203070003. Office phone: 2027826173.
What is Dr. Richard Burroughs's NPI?
Dr. Richard Burroughs's National Provider Identifier (NPI) is 1649250101, issued by NPPES.
Does Dr. Richard Burroughs accept Medicare assignment?
Dr. Richard Burroughs does not accept Medicare assignment for all services. Patients may be billed amounts beyond Medicare-allowed charges.
What procedures does Dr. Richard Burroughs commonly perform?
Top Medicare-reported procedures in 2023: Established patient office or other outpatient visit (HCPCS 99213); New patient office or other outpatient visit (HCPCS 99203); Destruction of skin growth, 1-14 growths (HCPCS 17110). Source: CMS Medicare Physician & Other Practitioners file.